Staphylococcus aureus-Derived α-Hemolysin Evokes Generation of Specialized Pro-resolving Mediators Promoting Inflammation Resolution

[1]  G. Krönke,et al.  12/15-Lipoxygenase during the regulation of inflammation, immunity, and self-tolerance , 2012, Journal of Molecular Medicine.

[2]  C. Glass,et al.  Phospholipase A2 regulates eicosanoid class switching during inflammasome activation , 2014, Proceedings of the National Academy of Sciences.

[3]  K. Horiuchi,et al.  Correction for Substrate Selectivity of Epidermal Growth Factor-Receptor Ligand Sheddases and their Regulation by Phorbol Esters and Calcium Influx , 2006, Molecular biology of the cell.

[4]  O. Werz.  5-lipoxygenase: cellular biology and molecular pharmacology. , 2002, Current drug targets. Inflammation and allergy.

[5]  David P. Roberson,et al.  Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314 , 2018, Nature Communications.

[6]  M. Otto.  Staphylococcus aureus toxins. , 2014, Current opinion in microbiology.

[7]  O. Werz,et al.  5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. , 2015, Biochimica et biophysica acta.

[8]  J. Duncan,et al.  ADAM10 Cell Surface Expression but Not Activity Is Critical for Staphylococcus aureus α-Hemolysin-Mediated Activation of the NLRP3 Inflammasome in Human Monocytes , 2016, Toxins.

[9]  O. Werz,et al.  In vivo sex differences in leukotriene biosynthesis in zymosan-induced peritonitis. , 2014, Pharmacological research.

[10]  P. Saftig,et al.  Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space. , 2014, Blood.

[11]  M. Otto,et al.  The psmα Locus Regulates Production of Staphylococcus aureus Alpha-Toxin during Infection , 2014, Infection and Immunity.

[12]  C. Serhan,et al.  Identification and Actions of a Novel Third Maresin Conjugate in Tissue Regeneration: MCTR3 , 2016, PloS one.

[13]  P. Lazarovici,et al.  Staphylococcus aureus α-toxin activates phospholipases and induces a Ca2+ influx in PC12 cells , 1989 .

[14]  C. Serhan,et al.  The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. , 2015, Seminars in immunology.

[15]  P. Isakson,et al.  In vivo characterization of zymosan-induced mouse peritoneal inflammation. , 1994, The Journal of pharmacology and experimental therapeutics.

[16]  D. Sturdevant,et al.  Role of the Accessory Gene Regulator agr in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis , 2011, Infection and Immunity.

[17]  H. Kuhn,et al.  Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15). , 2015, Gene.

[18]  O. Goldmann,et al.  Staphylococcus aureus strategies to evade the host acquired immune response. , 2017, International journal of medical microbiology : IJMM.

[19]  T. Foster.  Immune evasion by staphylococci , 2005, Nature Reviews Microbiology.

[20]  C. Wolz,et al.  Exotoxins from Staphylococcus aureus activate 5-lipoxygenase and induce leukotriene biosynthesis , 2019, Cellular and Molecular Life Sciences.

[21]  H. Monteil,et al.  Regulation of virulence determinants in Staphylococcus aureus: complexity and applications. , 2004, FEMS microbiology reviews.

[22]  Charles N Serhan,et al.  Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. , 2018, Journal of Clinical Investigation.

[23]  Vance G. Fowler,et al.  Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management , 2015, Clinical Microbiology Reviews.

[24]  J. Seong,et al.  Anti-inflammatory role of 15-lipoxygenase contributes to the maintenance of skin integrity in mice , 2018, Scientific Reports.

[25]  C. Bachert,et al.  Role of imbalance of eicosanoid pathways and staphylococcal superantigens in chronic rhinosinusitis , 2012, Allergy.

[26]  C. Serhan,et al.  Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. , 2014, American journal of physiology. Cell physiology.

[27]  S. Goerdt,et al.  Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.

[28]  H. Hammad,et al.  Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis , 2011, Allergy.

[29]  E. Reboud,et al.  Functional Consequences of Calcium Influx Promoted by Bacterial Pore-Forming Toxins , 2018, Toxins.

[30]  J. B. Wardenburg,et al.  Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin–mediated cellular injury , 2010, Proceedings of the National Academy of Sciences.

[31]  B. Mehramuz,et al.  The pathogenesis of Staphylococcus aureus in autoimmune diseases. , 2017, Microbial pathogenesis.

[32]  M. Fraunholz,et al.  Sigma Factor SigB Is Crucial to Mediate Staphylococcus aureus Adaptation during Chronic Infections , 2015, PLoS pathogens.

[33]  M. Fraunholz,et al.  Post-invasion events after infection with Staphylococcus aureus are strongly dependent on both the host cell type and the infecting S. aureus strain. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[34]  Gordon Y C Cheung,et al.  Phenol-soluble modulins--critical determinants of staphylococcal virulence. , 2014, FEMS microbiology reviews.

[35]  O. Werz,et al.  Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males , 2017, The Journal of clinical investigation.

[36]  C. Serhan,et al.  Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  W. Seeger,et al.  Staphylococcus aureus &agr;-toxin and Escherichia coli hemolysin impair cardiac regional perfusion and contractile function by activating myocardial eicosanoid metabolism in isolated rat hearts , 2009, Critical care medicine.

[38]  C. Serhan,et al.  Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections , 2015, Nature Medicine.

[39]  J. Bubeck Wardenburg,et al.  Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue , 2013, Toxins.

[40]  Charles N. Serhan,et al.  Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.

[41]  Eric P. Skaar,et al.  Haemin represses the haemolytic activity of Staphylococcus aureus in an Sae-dependent manner. , 2012, Microbiology.

[42]  J. Brock,et al.  Staphylococcus aureus Fibronectin Binding Proteins Are Essential for Internalization by Osteoblasts but Do Not Account for Differences in Intracellular Levels of Bacteria , 2001, Infection and Immunity.

[43]  P. Taylor,et al.  12/15-Lipoxygenase Regulates the Inflammatory Response to Bacterial Products In Vivo1 , 2008, The Journal of Immunology.

[44]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[45]  I. Inoshima,et al.  A Staphylococcus aureus Pore-Forming Toxin Subverts the Activity of ADAM10 to Cause Lethal Infection , 2011, Nature Medicine.

[46]  Charles N. Serhan,et al.  Resolvin E1 and protectin D1 activate inflammation-resolution programmes , 2007, Nature.

[47]  T. Schöneberg,et al.  Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. , 2010, Cell host & microbe.

[48]  R. Proctor,et al.  Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection , 2011, EMBO molecular medicine.

[49]  V. Torres,et al.  Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids. , 2014, Trends in microbiology.

[50]  Charles N. Serhan,et al.  Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.

[51]  Yun Zhang,et al.  Pore‐forming toxin‐like protein complex expressed by frog promotes tissue repair , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  D. Heydeck,et al.  Regulation of cellular 15-lipoxygenase activity on pretranslational, translational, and posttranslational levels , 2007, Lipids.

[53]  C. Serhan,et al.  Novel proresolving and tissue‐regenerative resolvin and protectin sulfido‐conjugated pathways , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  W. Seeger,et al.  Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin. , 1997, Journal of immunology.

[55]  H. Nakanishi,et al.  Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  H. Hartung,et al.  ADAM‐10 and ADAM‐17 in the inflamed human CNS , 2003, Glia.

[57]  W. Seeger,et al.  Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation. , 2000, Circulation.

[58]  C. Serhan,et al.  Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. , 2012, Blood.

[59]  D. Laouini,et al.  Role of Human Macrophage Polarization in Inflammation during Infectious Diseases , 2018, International journal of molecular sciences.

[60]  N. Voelkel,et al.  Role of eicosanoids in staphylococcal alpha-toxin-induced lung injury in the rat. , 1992, The American journal of physiology.

[61]  O. Werz,et al.  The novel benzimidazole derivative BRP‐7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5‐lipoxygenase‐activating protein (FLAP) , 2014, British journal of pharmacology.

[62]  C. Serhan,et al.  Macrophage Proresolving Mediators—the When and Where , 2016, Microbiology spectrum.

[63]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[64]  O. Werz,et al.  Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity , 2018, Nature Communications.

[65]  N. Hellmann,et al.  Staphylococcus aureus α-toxin: small pore, large consequences , 2019, Biological chemistry.

[66]  M. Perretti,et al.  Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis , 2009, Nature.

[67]  Àngels González-Lafont,et al.  Evolutionary alteration of ALOX15 specificity optimizes the biosynthesis of antiinflammatory and proresolving lipoxins , 2016, Proceedings of the National Academy of Sciences.

[68]  C. Leslie,et al.  Cytosolic Phospholipase A2 Is Required for Macrophage Arachidonic Acid Release by Agonists That Do and Do Not Mobilize Calcium , 2000, The Journal of Biological Chemistry.

[69]  Lei Wu,et al.  Fibrinogen-like protein 2 controls sepsis catabasis by interacting with resolvin Dp5 , 2019, Science Advances.

[70]  F. Lowy,et al.  Staphylococcus aureus infections: transmission within households and the community. , 2015, Trends in microbiology.

[71]  O. Werz,et al.  Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[73]  M. Otto.  Phenol-soluble modulins. , 2014, International journal of medical microbiology : IJMM.